nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Bronchitis—Epirubicin—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—urinary bladder cancer	0.000897	0.000897	CcSEcCtD
Naratriptan—Depression—Methotrexate—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Naratriptan—Hypotension—Etoposide—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Naratriptan—Pain—Cisplatin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Naratriptan—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000885	0.000885	CcSEcCtD
Naratriptan—Dizziness—Thiotepa—urinary bladder cancer	0.00088	0.00088	CcSEcCtD
Naratriptan—Urticaria—Fluorouracil—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—urinary bladder cancer	0.000872	0.000872	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—urinary bladder cancer	0.00087	0.00087	CcSEcCtD
Naratriptan—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00087	0.00087	CcSEcCtD
Naratriptan—Sweating—Methotrexate—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Naratriptan—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Naratriptan—Paraesthesia—Etoposide—urinary bladder cancer	0.000858	0.000858	CcSEcCtD
Naratriptan—Dyspnoea—Etoposide—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00085	0.00085	CcSEcCtD
Naratriptan—Somnolence—Etoposide—urinary bladder cancer	0.00085	0.00085	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000849	0.000849	CcSEcCtD
Naratriptan—Vomiting—Thiotepa—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—urinary bladder cancer	0.000845	0.000845	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Naratriptan—Rash—Thiotepa—urinary bladder cancer	0.000839	0.000839	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Naratriptan—Dermatitis—Thiotepa—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Naratriptan—Headache—Thiotepa—urinary bladder cancer	0.000833	0.000833	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000825	0.000825	CcSEcCtD
Naratriptan—Body temperature increased—Cisplatin—urinary bladder cancer	0.000825	0.000825	CcSEcCtD
Naratriptan—Fatigue—Etoposide—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000823	0.000823	CcSEcCtD
Naratriptan—Pain—Etoposide—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Naratriptan—Constipation—Etoposide—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Naratriptan—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000811	0.000811	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—urinary bladder cancer	0.00081	0.00081	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—urinary bladder cancer	0.000806	0.000806	CcSEcCtD
Naratriptan—Sweating—Epirubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Naratriptan—Asthenia—Gemcitabine—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000796	0.000796	CcSEcCtD
Naratriptan—Pruritus—Gemcitabine—urinary bladder cancer	0.000792	0.000792	CcSEcCtD
Naratriptan—Nausea—Thiotepa—urinary bladder cancer	0.00079	0.00079	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—urinary bladder cancer	0.000788	0.000788	CcSEcCtD
Naratriptan—Feeling abnormal—Etoposide—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—urinary bladder cancer	0.000782	0.000782	CcSEcCtD
Naratriptan—Pruritus—Fluorouracil—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—urinary bladder cancer	0.000777	0.000777	CcSEcCtD
Naratriptan—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000768	0.000768	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—urinary bladder cancer	0.000768	0.000768	CcSEcCtD
Naratriptan—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000762	0.000762	CcSEcCtD
Naratriptan—Urticaria—Etoposide—urinary bladder cancer	0.000759	0.000759	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Naratriptan—Body temperature increased—Etoposide—urinary bladder cancer	0.000755	0.000755	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000753	0.000753	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—urinary bladder cancer	0.000751	0.000751	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00075	0.00075	CcSEcCtD
Naratriptan—Asthenia—Cisplatin—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Naratriptan—Chills—Methotrexate—urinary bladder cancer	0.000723	0.000723	CcSEcCtD
Naratriptan—Diarrhoea—Cisplatin—urinary bladder cancer	0.000714	0.000714	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—urinary bladder cancer	0.000712	0.000712	CcSEcCtD
Naratriptan—Vomiting—Gemcitabine—urinary bladder cancer	0.000712	0.000712	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—urinary bladder cancer	0.00071	0.00071	CcSEcCtD
Naratriptan—Rash—Gemcitabine—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Naratriptan—Dermatitis—Gemcitabine—urinary bladder cancer	0.000705	0.000705	CcSEcCtD
Naratriptan—Hypersensitivity—Etoposide—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—urinary bladder cancer	0.000703	0.000703	CcSEcCtD
Naratriptan—Erythema—Methotrexate—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Naratriptan—Headache—Gemcitabine—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000698	0.000698	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Naratriptan—Rash—Fluorouracil—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Naratriptan—Headache—Fluorouracil—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Naratriptan—Asthenia—Etoposide—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—urinary bladder cancer	0.000684	0.000684	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Naratriptan—Chills—Epirubicin—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Naratriptan—Pruritus—Etoposide—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—urinary bladder cancer	0.000674	0.000674	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Naratriptan—Nausea—Gemcitabine—urinary bladder cancer	0.000665	0.000665	CcSEcCtD
Naratriptan—Vomiting—Cisplatin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—urinary bladder cancer	0.000661	0.000661	CcSEcCtD
Naratriptan—Rash—Cisplatin—urinary bladder cancer	0.000658	0.000658	CcSEcCtD
Naratriptan—Dermatitis—Cisplatin—urinary bladder cancer	0.000657	0.000657	CcSEcCtD
Naratriptan—Erythema—Epirubicin—urinary bladder cancer	0.000656	0.000656	CcSEcCtD
Naratriptan—Diarrhoea—Etoposide—urinary bladder cancer	0.000654	0.000654	CcSEcCtD
Naratriptan—Nausea—Fluorouracil—urinary bladder cancer	0.000654	0.000654	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000651	0.000651	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—urinary bladder cancer	0.00065	0.00065	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000647	0.000647	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Naratriptan—Malaise—Methotrexate—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Naratriptan—Dizziness—Etoposide—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—urinary bladder cancer	0.000631	0.000631	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Naratriptan—Chills—Doxorubicin—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Naratriptan—Nausea—Cisplatin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—urinary bladder cancer	0.000616	0.000616	CcSEcCtD
Naratriptan—Cough—Methotrexate—urinary bladder cancer	0.000612	0.000612	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Naratriptan—Vomiting—Etoposide—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—urinary bladder cancer	0.000607	0.000607	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—urinary bladder cancer	0.000607	0.000607	CcSEcCtD
Naratriptan—Agitation—Epirubicin—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Naratriptan—Rash—Etoposide—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Naratriptan—Dermatitis—Etoposide—urinary bladder cancer	0.000602	0.000602	CcSEcCtD
Naratriptan—Headache—Etoposide—urinary bladder cancer	0.000599	0.000599	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Naratriptan—Malaise—Epirubicin—urinary bladder cancer	0.000592	0.000592	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—urinary bladder cancer	0.00059	0.00059	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—urinary bladder cancer	0.00059	0.00059	CcSEcCtD
Naratriptan—Syncope—Epirubicin—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000584	0.000584	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—urinary bladder cancer	0.00058	0.00058	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Naratriptan—Cough—Epirubicin—urinary bladder cancer	0.000573	0.000573	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000572	0.000572	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—urinary bladder cancer	0.000572	0.000572	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—urinary bladder cancer	0.000569	0.000569	CcSEcCtD
Naratriptan—Infection—Methotrexate—urinary bladder cancer	0.000569	0.000569	CcSEcCtD
Naratriptan—Nausea—Etoposide—urinary bladder cancer	0.000568	0.000568	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000563	0.000563	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—urinary bladder cancer	0.000559	0.000559	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—urinary bladder cancer	0.000559	0.000559	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—urinary bladder cancer	0.000558	0.000558	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—urinary bladder cancer	0.000557	0.000557	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—urinary bladder cancer	0.000556	0.000556	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000553	0.000553	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—urinary bladder cancer	0.000552	0.000552	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—urinary bladder cancer	0.000548	0.000548	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—urinary bladder cancer	0.000545	0.000545	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—urinary bladder cancer	0.000537	0.000537	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Naratriptan—Oedema—Epirubicin—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—urinary bladder cancer	0.000535	0.000535	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000534	0.000534	CcSEcCtD
Naratriptan—Infection—Epirubicin—urinary bladder cancer	0.000532	0.000532	CcSEcCtD
Naratriptan—Cough—Doxorubicin—urinary bladder cancer	0.00053	0.00053	CcSEcCtD
Naratriptan—Shock—Epirubicin—urinary bladder cancer	0.000527	0.000527	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—urinary bladder cancer	0.000526	0.000526	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000521	0.000521	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—urinary bladder cancer	0.00052	0.00052	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000518	0.000518	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—urinary bladder cancer	0.000517	0.000517	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—urinary bladder cancer	0.000517	0.000517	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—urinary bladder cancer	0.000515	0.000515	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—urinary bladder cancer	0.00051	0.00051	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—urinary bladder cancer	0.000509	0.000509	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—urinary bladder cancer	0.000506	0.000506	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—urinary bladder cancer	0.000501	0.000501	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—urinary bladder cancer	0.0005	0.0005	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000496	0.000496	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—urinary bladder cancer	0.000496	0.000496	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000494	0.000494	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—urinary bladder cancer	0.000493	0.000493	CcSEcCtD
Naratriptan—Infection—Doxorubicin—urinary bladder cancer	0.000492	0.000492	CcSEcCtD
Naratriptan—Pain—Methotrexate—urinary bladder cancer	0.000489	0.000489	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000488	0.000488	CcSEcCtD
Naratriptan—Shock—Doxorubicin—urinary bladder cancer	0.000488	0.000488	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000486	0.000486	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000479	0.000479	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—urinary bladder cancer	0.000478	0.000478	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—urinary bladder cancer	0.000476	0.000476	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000472	0.000472	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—urinary bladder cancer	0.000463	0.000463	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000462	0.000462	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—urinary bladder cancer	0.000462	0.000462	CcSEcCtD
Naratriptan—Pain—Epirubicin—urinary bladder cancer	0.000458	0.000458	CcSEcCtD
Naratriptan—Constipation—Epirubicin—urinary bladder cancer	0.000458	0.000458	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—urinary bladder cancer	0.000455	0.000455	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—urinary bladder cancer	0.000452	0.000452	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000452	0.000452	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000445	0.000445	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000442	0.000442	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000441	0.000441	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—urinary bladder cancer	0.000441	0.000441	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000428	0.000428	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—urinary bladder cancer	0.000427	0.000427	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—urinary bladder cancer	0.000426	0.000426	CcSEcCtD
Naratriptan—Pain—Doxorubicin—urinary bladder cancer	0.000424	0.000424	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—urinary bladder cancer	0.000424	0.000424	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—urinary bladder cancer	0.000423	0.000423	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000422	0.000422	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—urinary bladder cancer	0.000411	0.000411	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—urinary bladder cancer	0.000405	0.000405	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000395	0.000395	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—urinary bladder cancer	0.000394	0.000394	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000392	0.000392	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—urinary bladder cancer	0.000392	0.000392	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—urinary bladder cancer	0.000384	0.000384	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—urinary bladder cancer	0.000379	0.000379	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—urinary bladder cancer	0.000379	0.000379	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—urinary bladder cancer	0.000366	0.000366	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000365	0.000365	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—urinary bladder cancer	0.000364	0.000364	CcSEcCtD
Naratriptan—Rash—Methotrexate—urinary bladder cancer	0.000361	0.000361	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—urinary bladder cancer	0.000361	0.000361	CcSEcCtD
Naratriptan—Headache—Methotrexate—urinary bladder cancer	0.000359	0.000359	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—urinary bladder cancer	0.000356	0.000356	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—urinary bladder cancer	0.000354	0.000354	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—urinary bladder cancer	0.000351	0.000351	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—urinary bladder cancer	0.000341	0.000341	CcSEcCtD
Naratriptan—Nausea—Methotrexate—urinary bladder cancer	0.00034	0.00034	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000339	0.000339	CcSEcCtD
Naratriptan—Rash—Epirubicin—urinary bladder cancer	0.000338	0.000338	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—urinary bladder cancer	0.000337	0.000337	CcSEcCtD
Naratriptan—Headache—Epirubicin—urinary bladder cancer	0.000336	0.000336	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—urinary bladder cancer	0.000328	0.000328	CcSEcCtD
Naratriptan—Nausea—Epirubicin—urinary bladder cancer	0.000318	0.000318	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—urinary bladder cancer	0.000315	0.000315	CcSEcCtD
Naratriptan—Rash—Doxorubicin—urinary bladder cancer	0.000313	0.000313	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—urinary bladder cancer	0.000312	0.000312	CcSEcCtD
Naratriptan—Headache—Doxorubicin—urinary bladder cancer	0.00031	0.00031	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—urinary bladder cancer	0.000294	0.000294	CcSEcCtD
